[EN] ISONIPECOTAMIDES FOR THE TREATMENT OF INTEGRIN-MEDIATED DISORDERS<br/>[FR] ISONIPECOTAMIDES DESTINEES AU TRAITEMENT DE MALADIES PROVOQUEES PAR L'INTEGRINE
申请人:ORTHO MCNEIL PHARM INC
公开号:WO2001023376A1
公开(公告)日:2001-04-05
The invention is directed to novel isonipecotamide derivatives of Formula (I), which are useful in treating integrin-mediated disorders.